Canine Cognitive Dysfunction (CCD), often referred to as “dog Alzheimer’s,” is a prevalent and progressive neurobehavioral syndrome affecting senior and geriatric dogs. CCD is not simply “old age” but a recognizable disease process analogous to Alzheimer’s disease in humans. It results from age-related neurodegenerative changes, including the accumulation of \beta-amyloid plaques and cerebral atrophy, leading to impaired cognitive function.
CCD is very common, with the following signs often seen:
-
Disorientation (spatial and temporal): Pacing aimlessly, getting stuck in corners, staring blankly, or failing to recognize familiar people/places.
-
Interactions (altered): Reduced interest in play or greeting, increased irritability, or increased dependence/clinginess.
-
Sleep-Wake Cycle Alterations: Restlessness or pacing at night, excessive daytime sleeping.
-
House-soiling: Accidents indoors despite being reliably house-trained.
-
Activity Changes: Decreased or increased purpose-less activity (e.g., compulsive licking, pacing).
Management strategies typically involve a multimodal approach:
-
Pharmaceuticals: Use of selegiline (a monoamine oxidase B inhibitor) is approved to help manage symptoms. Other supportive medications, such as S-adenosylmethionine (SAMe) or specific anxiolytics, may be prescribed based on the dog’s primary symptoms.
-
Nutritional Support: Diets enriched with antioxidants (e.g. medium-chain triglycerides (MCTs) have been shown to provide an alternative energy source for the aging brain and improve cognitive function in some dogs.
-
Environmental Enrichment: Maintaining a predictable routine, using environmental aids (e.g., nightlights, ramps), and providing gentle, consistent cognitive exercise (e.g., puzzle toys, short training sessions) are essential.
Listen to the discussion on Newstalk by clicking on this link.
Please note that I am unable to answer veterinary questions in comments. If you have questions or concerns about your pet's health it is always better to contact your vet.